Citation Impact
Citing Papers
HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol
2005 Standout
The inflammatory process of gout and its treatment.
2006
Macrophage metabolic reprogramming during chronic lung disease
2020
OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines
2008 Standout
Clinical features and aetiology of septic arthritis in northern Israel
2005
Molecular identification of a renal urate–anion exchanger that regulates blood urate levels
2002 StandoutNature
Gout: can management be improved?
2001
Radiographic patterns and response to corticosteroid hip injection
1997
Macrophages in immunoregulation and therapeutics
2023 Standout
Gout
2009 Standout
Scleroderma
2009 Standout
EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT)
2006 Standout
Corticosteroids in rheumatoid arthritis
1989
Sclerodermalike Esophageal Disease in Children Breast-fed by Mothers With Silicone Breast Implants
1994
Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States
1998 Standout
Pharmacoeconomics of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
1993
Caspase Functions in Cell Death and Disease
2013 Standout
Research diagnostic criteria for temporomandibular disorders (RDC/TMD): development of image analysis criteria and examiner reliability for image analysis
2009 Standout
Effects of triamcinolone acetonide on an in vivo equine osteochondral fragment exercise model
1997
Natural forms of vitamin E: metabolism, antioxidant, and anti-inflammatory activities and their role in disease prevention and therapy
2014 Standout
Gout in Solid Organ Transplantation
2005
Therapeutic Effects of Xanthine Oxidase Inhibitors: Renaissance Half a Century after the Discovery of Allopurinol
2006 Standout
Familial risk estimation in systemic sclerosis
1999
Metabolic orchestration of the wound healing response
2021
2‐Chloroadenosine but not adenosine induces apoptosis in rheumatoid fibroblasts independently of cell surface adenosine receptor signalling
2002 StandoutNobel
Febuxostat Compared with Allopurinol in Patients with Hyperuricemia and Gout
2005 Standout
Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases
2008 Standout
Systemic steroid therapy for acute gout: A clinical trial and review of the literature
1990
Risk factors for septic arthritis in patients with joint disease
1995
Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
2016 Standout
Treatment of experimental equine osteoarthritis by in vivo delivery of the equine interleukin-1 receptor antagonist gene
2002 Standout
Epidemiology and Estimated Population Burden of Selected Autoimmune Diseases in the United States
1997 Standout
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Incidence and sources of native and prosthetic joint infection: a community based prospective survey
1997
Drug Treatment for Rheumatoid Arthritis
1999
Bias in meta-analysis detected by a simple, graphical test
1997 Standout
Management of Acute and Chronic Gouty Arthritis
2004
The Management of Gout
1996
Nrf2 activation improves experimental rheumatoid arthritis
2023 StandoutNobel
Global epidemiology of gout: prevalence, incidence and risk factors
2015 Standout
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Benefits and risks of intralesional corticosteroid injection in the treatment of dermatological diseases
1995
Localized scleroderma-response to 1,25-dihydroxyvitamin D3
1990 Standout
European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa
2015 Standout
Interventions for managing temporomandibular joint osteoarthritis
2012
Degenerative Disorders of the Temporomandibular Joint: Etiology, Diagnosis, and Treatment
2008 Standout
Epidemiology of Progressive Systemic Sclerosis
1979
Gout: a review of its aetiology and treatment.
2004
Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine
2010
Gold Nanoparticles: A Revival in Precious Metal Administration to Patients
2011 Standout
Current Understanding of Pathogenesis and Treatment of TMJ Osteoarthritis
2015 Standout
The immunopathology of progressive systemic sclerosis (PSS)
1982
Rheumatic Diseases of Childhood
1990
Comparison of the Kinetics of Parenteral and Oral Gold
1983
Works of Robert Gray being referenced
Progressive systemic sclerosis in a family
1977
Intra-articular Corticosteroids
1983
Diagnosis and Management of Adverse Reactions From Gold Compounds
1978
Itaconate controls the severity of pulmonary fibrosis
2020
Pharmacokinetics of gold in rheumatoid arthritis.
1981
Local corticosteroid injection treatment in rheumatic disorders
1981